retatrutide phase 2 trial Mazdutide vs retatrutide: dual agonist meets triple agonist in the next-gen weight loss showdown Triple hormone receptor agonist retatrutide

Understanding Beyond-Use Dates (BUD) The Beyond-Use Date (BUD) is the final date that a compounded medication remains safe and effective

New Patient Doctor Visit $99 Includes Complementary Seca Body Composition Measurement & Medication Prescription (If Needed) Welcome New Patients to JosephCareRX, Medical Weight Loss Clinic in Fayetteville, NC JosephCareRX is a premier medical weight loss clinic in Fayetteville, NC, committed to helping you achieve your health and wellness goals through personalized, medically supervised programs

Peak Performance and Eddie are wonderful

We saw about a 30% increase in GLP-1 cost. HR Director, large manufacturer Many focus group participants reported that their firms will no longer cover GLP-1 agonists for weight loss due to the increases in use and costs

Studying GLP-1 + GIP + glucagon triple agonism in a single molecule retatrutide

Excessive caloric restriction risks nutritional deficiencies and metabolic adaptation that undermine research objectives